NCT01588639 - To Evaluate Clinical Outcome and Injection Compliance of Scilin | Biotech Hunter

Enrollment

2,683

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin (Scilin N, BAY81-9924)

Subjects are treated with recombinant human insulin-SciLin N, SciLin R and SciLin M30 (alone or in combination) in routine clinical practice.

DRUG

Insulin (Scilin R _BAY81-9924

Subjects are treated with recombinant human insulin-SciLin N, SciLin R and SciLin M30 (alone or in combination) in routine clinical practice

DRUG

Insulin(Scilin M30_BAY81-9924)

Subjects are treated with recombinant human insulin-SciLin N, SciLin R and SciLin M30 (alone or in combination) in routine clinical practice

Trial Locations (1)

Many Locations